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Abstract The objective of this study was to summarize
outcomes of subintimal angioplasty (SA) for peripheral
arterial occlusive disease. The Cochrane Library, Medline
andEmbasedatabasesweresearchedtoperformasystematic
review of the literature from 1966 through May 2007 on
outcomes of SA for peripheral arterial occlusive disease of
the infrainguinal vessels. The keywords ‘‘percutaneous
intentional extraluminal revascularization,’’ ‘‘subintimal
angioplasty,’’ ‘‘peripheral arterial disease,’’ ‘‘femoral
artery,’’ ‘‘popliteal artery,’’ and ‘‘tibial artery’’ were used.
Assessment of study quality was done usinga form based on
a checklist of the Dutch Cochrane Centre. The recorded
outcomes were technical and clinical success, primary
(assisted) patency, limb salvage, complications, and sur-
vival, inrelation tothe clinical grade of disease (intermittent
claudication or critical limb ischemia [CLI] or mixed) and
location of lesion (femoropopliteal, crural, or mixed).
Twenty-three cohort studies including a total of 1549
patients (range, 27 to 148) were included in this review.
Methodological and reporting quality were moderate, e.g.,
there was selection bias and reporting was not done
according to the reporting standards. These and signiﬁcant
clinical heterogeneity obstructed a meta-analysis. Reports
about length of the lesion and TASC classiﬁcation were too
various to summarize or were not mentioned at all. The
technical success rates varied between 80% and 90%, with
lowerratesforcrurallesionscomparedwithfemorallesions.
Complication rates ranged between 8% and 17% and most
complicationswereminor.After1 year,clinicalsuccesswas
between 50% and 70%, primary patency was around 50%
and limb salvage varied from 80% to 90%. In conclusion,
taking into account the methodological shortcomings of the
included studies, SA can play an important role in the
treatmentofperipheralarterialdisease,especiallyinthecase
ofcriticallimbischemia.Despitethemoderatepatencyrates
after one year, SA may serve as a ‘‘temporary bypass’’ to
provide wound healing and limb salvage.
Keywords Subintimal angioplasty 
Peripheral arterial disease  Revascularization 
Percutaneous intentional extraluminal recanalization 
Systematic review
Introduction
Since it was ﬁrst described in 1990 [1], subintimal angio-
plasty (SA) has become an established percutaneous
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It is also known as percutaneous intentional extraluminal
recanalization (PIER) [2]. Initially it was used only for
femoral and popliteal occlusions, but now it is also applied
to long crural artery occlusions [3]. This therapy, being
minimally invasive, offers many advantages compared
with other treatment options. Patients need only local
anesthesia to enable access to the common femoral artery,
and after the procedure they are quickly ambulatory again.
In addition, failed SA does not preclude the opportunity for
surgical revascularization [4]. Despite these advantages,
there are also specialists who adopt a critical attitude
toward SA. They state that it is difﬁcult to learn, that the
long-term results are not known, and that there are no
randomized studies comparing SA with surgery. To
determine the clinical value of this technique, a systematic
review of available evidence is needed. The aim of this
study was to systematically review the literature on the
technical and clinical outcomes of subintimal angioplasty
for peripheral arterial occlusive disease.
Methods
Literature Search
A systematic search of literature was performed with
assistance of a clinical librarian in the medical databases
National Guideline Clearinghouse, Trip database, Bando-
lier, British Medical Journal Clinical Evidence, Medline
(January 1966 through May 2007), Embase (January 1980
through May 2007), and Cochrane Library, comprising the
Database of Systematic Reviews (1988 through May
2007). The keywords ‘‘percutaneous intentional extra-
luminal revascularization,’’ ‘‘subintimal angioplasty,’’
‘‘peripheral arterial disease,’’ ‘‘femoral artery,’’ ‘‘popliteal
artery,’’ and ‘‘tibial artery’’ were used, along with syn-
onyms of them. There was no language restriction. Titles
and abstracts were screened by two reviewers (R.M. and
K.P.L.) independently to identify potentially relevant arti-
cles, using the inclusion and exclusion criterion.
Discrepancies in judgment were resolved after discussion
and, when necessary, after mediation of a third reviewer
(S.B.). Full text of these articles was retrieved for further
analysis.
Criteria for Inclusion
The same two reviewers (R.M. and K.P.L.) independently
checked the retrieved articles on inclusion criteria using a
standardized form. Clinical studies were selected when all
of the inclusion criteria were met. First, patients had to be
treated for a femoral, popliteal, or crural occlusion by SA
(studies reporting a maximum of 5% iliac occlusions were
also included). Second, at least one of the following out-
come parameters of interest—i.e., technical success,
primary patency after 1 year, and limb salvage after
1 year—had to be reported. Technical success was deﬁned
as good antegrade ﬂow at completion of the procedure.
Primary patency after 1 year must be measured by an
established imaging technique, i.e., duplex scanning,
computed tomography angiography (CTA), magnetic res-
onance angiography (MRA), or digital subtraction
angiography (DSA). Third, the study should include a
minimum of 10 patients. Fourth, it should be an original
patient series (studies containing duplicate material were
excluded and the ones with the best documented material
were included for analysis).
Study Quality
Studies fulﬁlling all inclusion criteria were checked on
study quality characteristics by two reviewers (R.M. and
K.P.L.) independently. Assessment of study quality was
done using a form based on a checklist of the Dutch
Cochrane Centre [5]. The main points of appraisal included
description of (1) patient selection, (2) patient character-
istics, (3) location of lesion, (4) technique, (5) follow-up,
(6) assessment of patency, and (7) deﬁnition of outcome.
Each item was described clearly, described moderate to
badly, or not described at all. Articles were considered to
be valid and selected for data extraction if items 2, 3, 4, and
7 were described clearly. An article could be included,
despite incomplete or very short follow-up, because one
important outcome, i.e., technical success, is independent
of follow-up.
Data Extraction
The following data were recorded per study: method of
data collection (prospective or retrospective), selection of
patients for the intervention (indication for SA), and
selection of patients for the study (consecutive or selected
and, if selected, inclusion and exclusion criteria). Further-
more, patient characteristics (number of patients, sex, age,
indication [claudication, rest pain, gangrene], and most
important risk factors, i.e., diabetes, smoking, hyperten-
sion, renal failure) and characteristics of treated lesions
(location, length, outﬂow) were recorded. Finally, data
about the procedure were collected such as technique
(materials, stent placement, anticoagulants during proce-
dure), performer (number of different interventional
radiologists, experience), use of anticoagulants after the
procedure, and follow-up data.
The following outcomes were recorded and analyzed:
technical and clinical success, primary (assisted) patency,
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123limb salvage, complications, and survival. Data extraction
was done by two reviewers (R.M. and K.P.L.) indepen-
dently. Discrepancies in evaluation were resolved after
discussion and, when necessary, after mediation of a third
reviewer (S.B.).
Data Analysis
The studies were subdivided into different groups accord-
ing to the clinical grade of disease (intermittent
claudication [IC] or critical limb ischemia [CLI] or mixed)
and location of lesion (femoral-popliteal, crural, or mixed).
Studies that included mainly patients with CLI and\15%
patients with IC were analyzed in the CLI group, and vice
versa. A mixed patient population was deﬁned as a patient
group consisting of both [15% claudicants as well as
[15% CLI patients. We intended to perform a meta-
analysis if data were clinically homogeneous by calculating
summary estimates with nonlinear models using either
random-effects or ﬁxed-effects approaches.
Many studies reported patency and limb salvage only for
cases which were technically successful. For this system-
atic review we considered technically unsuccessful cases as
not patent and calculated patency rates and limb salvage
rates for the total group of treated patients, including
technically unsuccessful cases.
Reporting was according to the consensus statement of
the Meta-analysis Of Observational Studies in Epidemiol-
ogy (MOOSE) group [6].
Results
Search Strategy and Study Selection
The initial search yielded 151 articles (Fig. 1). After
screening of title and abstract, 105 articles were excluded.
The most frequent reasons for exclusion were study design
(review, case report), technique (other than SA), and
location of lesion (iliac artery or extending from the fem-
oral into the iliac artery). For the remaining 46 papers, two
full copies [7, 8] could not be obtained, and translation of
one Lithuanian article [9] was not possible. After assess-
ment of 43 full text publications, 20 articles were excluded,
mainly because of inadequate description of patient or
lesion characteristics or use of another (sometimes exper-
imental) endovascular technique.
Finally, 23 articles [2, 10–31] were included in this
review. We did not ﬁnd randomized controlled trials. Most
of the studies were retrospective (n = 11) or prospective
(n = 8) patient series. In four studies, it remained unclear
whether data collection was pro- or retrospective [13, 15,
19, 29]. Quality assessment of the studies is shown in
Table 1.
Study Characteristics
Characteristics of all included studies are shown in
Tables 2, 3, 4. The authors often described that they
included consecutive patients undergoing SA, but the
selection procedure for the treatment remained unclear. If it
was described, there was a large variation in patient
selection. Two studies [13, 28] included patients in whom
amputation was inevitable without treatment; two other
studies [17, 18] selected every patient presenting with
critical limb ischemia; ﬁve studies [11, 19, 21, 26, 29]
included patients who met one of the following conditions:
(a) lack of vein suitable for surgical reconstruction, (b)
poor medical condition, (c) unfavorable anatomy for
bypass grafting, and (d) favorable anatomy for SA. One
study [31] selected only patients who refused surgery or in
whom surgery was contraindicated. The studies varied in
size from 27 to 148 patients. Studies reported age in dif-
ferent ways: some gave median age; others, mean age. The
ages were between 59 and 81 years; most studies (16/23)
reported ages (some mean and others median) between 70
and 80 years. The percentage of diabetic patients between
studies showed a large variation (9%–72%). However, the
percentage of patients with diabetes was higher in the
group of patients treated for CLI (Table 2) compared with
the group of patients treated for mixed indications (inter-
mittent claudication or CLI; Table 3). Also, there was a
trend that there were more diabetics in the group of patients
with mixed disease and mixed lesions compared with
patients with mixed disease and a lesion proximal to the
knee. Chronic renal failure is not included in the tables
because only 9 of 23 articles mentioned it. Use of antico-
agulants during the procedure was described in 14 articles;
all patients received heparin, with a variation in dose of
50–70 IU/kg or 2000–5000 IU. Some also received nitro-
glycerin or tolazoline (intra-arterial vasodilating agents to
Publications identified after 
search n = 151 
Publications selected on title 
and / or abstract n = 46 
Publications obtained in 
full-text   n = 43 
Excluded n = 3 
   translation not possible n = 1 
   full-text could not be obtained n = 2 
Considered not relevant based on title 
and / or abstract n = 105 
Excluded based on full-text n = 20 
Articles eligible for analysis 
n = 23 
Fig. 1 Flowchart showing selection of papers for analysis
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123minimize vasospasms) during the procedure. Nearly all
papers had well-described postprocedural anticoagulant
therapy. All patients were given acetylsalicylic acid,
sometimes combined with clopidogrel. Only very few
papers report the use of additional devices (like stents). The
use of re-entry devices is described nowhere. The signiﬁ-
cant clinical heterogeneity obstructed a meaningful meta-
analysis.
Technical Success
Most studies described technical success as good antegrade
ﬂow of the occluded segment at completion of the proce-
dure. Some studies added the condition that there was
\30% residual stenosis [11, 20, 23, 25, 28, 31]. Technical
success percentages (95% conﬁdence interval) are shown
in Figs. 2, 3, and 4. In patients with critical limb ischemia,
technical success of crural procedures is lower compared
with that for femoral lesions. For patients treated for dif-
ferent disease (CLI or intermittent claudication), technical
success rate show a large variation. In general, technical
success is between 80% and 90%.
Clinical Success
Nine studies reported clinical success, described as reso-
lution or improvement of claudication, relief of pain at rest,
healing of ulcers, or healing of minor amputations which
were required for gangrene and nonhealing wounds after
previous amputation. Clinical success was achieved in 50%
to 70% of the patients after 1 year (Tables 5, 6, 7).
Patency
The deﬁnition and reporting of patency varied considerably
between studies. Some studies reported primary patency;
others primary assisted patency. Primary patency was
deﬁned differently among studies as (1) absence of
occlusion and absence of [50% stenosis in the treated
segment; (2) absence of occlusion and absence of [30%
Table 1 Quality assessment of all included studies
Study Year of
publication
Clear
deﬁnition
of study
population?
Clear
description
of patient
characteristics?
Clear
description
of lesions?
Clear
description
of
technique?
Follow-up
complete?
Objective
assessment
of patency?
>Clear
deﬁnition
of
outcomes?
Sum
a
London [20] 1994 ++ ++ - + /-+ 11
Reekers [2] 1994 ++ ++ + /-+ /-+ /- 11
Nydahl [23] 1997 ++ ++ + ++ 14
McCarthy [21] 2000 ++ +- + /-+ + 11
Vraux & Hammer [29] 2000 ++ ++ + /-+ + 13
Ingle [14] 2002 ++ ++ + -+ /- 11
Shaw [24] 2002 ++ +- + ++ 12
Tisi [27] 2002 ++ ++ /-+ ? + 11
Laxdal [16] 2003 ++ ++ - ++ 12
Lipsitz [19] 2003 ++ ++ - ++ /- 11
Yilmaz [31] 2003 ++ ++ - ++ 12
Desgranges [11] 2004 ++ ++ - ++ /- 11
Florenes [12] 2004 ++ + /-+ + + - 11
Hynes [13] 2004 ++ /-+ -+ + +11
Lazaris & Tsiamis [17] 2004 ++ +- - ? + 8
Spinosa [26] 2004 ++ ++ + /-+ /-+ 12
Smith [25] 2005 ++ ++ + + /-+ 13
Cho [10] 2006 ++ ++ - ++ 12
Kidd [15] 2006 ++ ++ + ++ 13
Lazaris & Salas [18] 2006 ++ +- - +- 8
Myers [22] 2006 ++ + /-+ + + + 13
Treiman [28] 2006 ++ ++ + ++ 14
Vraux & Bertoncello [30] 2006 ++ ++ + /-+ + 13
(+) yes; (-) no; (+/-) moderate; (?) unclear
a Sum of all seven quality indicators: yes = 2 point, moderate = 1 point, no or ? = 0 points
690 R. Met et al.: Subintimal Angioplasty for Peripheral Arterial Occlusive Disease: A Systematic Review
123T
a
b
l
e
2
C
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
i
n
c
l
u
d
e
d
s
t
u
d
i
e
s
r
e
p
o
r
t
i
n
g
a
b
o
u
t
p
a
t
i
e
n
t
s
w
i
t
h
c
r
i
t
i
c
a
l
l
i
m
b
i
s
c
h
e
m
i
a
,
s
u
b
d
i
v
i
d
e
d
a
c
c
o
r
d
i
n
g
t
o
l
o
c
a
t
i
o
n
o
f
l
e
s
i
o
n
(
c
r
u
r
a
l
,
f
e
m
o
r
a
l
o
r
f
e
m
o
r
o
p
o
p
l
i
t
e
a
l
v
e
s
s
e
l
s
o
r
m
i
x
e
d
,
w
h
i
c
h
a
r
e
a
l
l
i
n
f
r
a
i
n
g
u
i
n
a
l
)
S
t
u
d
y
N
o
.
o
f
p
a
t
i
e
n
t
s
,
l
i
m
b
s
F
o
n
t
a
i
n
e
g
r
a
d
e
P
a
t
i
e
n
t
a
g
e
,
y
r
(
r
a
n
g
e
)
P
a
t
i
e
n
t
C
h
a
r
a
c
t
e
r
i
s
t
i
c
s
L
o
c
a
t
i
o
n
o
f
l
e
s
i
o
n
s
F
o
l
l
o
w
-
u
p
,
m
o
(
r
a
n
g
e
)
L
e
s
i
o
n
(
m
o
s
t
l
y
)
i
n
c
r
u
r
a
l
v
e
s
s
e
l
s
I
n
g
l
e
[
1
4
]
6
7
,
7
0
I
I
6
(
9
%
)
M
e
a
n
:
7
6
(
4
1
–
9
6
)
D
M
:
3
1
(
4
6
%
)
C
A
:
7
0
(
6
–
4
4
)
I
I
I
2
1
(
3
1
%
)
H
T
:
3
6
(
5
4
%
)
I
V
4
0
(
6
0
%
)
S
m
o
k
i
n
g
:
3
9
(
5
8
%
)
N
y
d
a
h
l
[
2
3
]
2
7
,
2
8
I
I
I
4
(
1
4
%
)
M
e
d
i
a
n
:
8
1
(
4
8
–
8
8
)
D
M
:
9
(
3
3
%
)
C
A
:
2
8
N
o
o
n
e
l
o
s
t
t
o
F
U
(
1
8
–
4
8
)
I
V
2
4
(
8
6
%
)
H
T
:
9
(
3
3
%
)
S
m
o
k
i
n
g
:
4
(
1
5
%
)
V
r
a
u
x
&
H
a
m
m
e
r
[
2
9
]
3
6
,
4
0
I
I
I
9
(
2
3
%
)
M
e
d
i
a
n
:
7
0
(
3
6
–
9
0
)
D
M
:
2
6
(
7
2
%
)
P
A
-
C
A
:
8
(
2
0
%
)
M
e
d
i
a
n
:
1
0
(
1
–
2
4
)
I
V
3
1
(
7
7
%
)
H
T
:
1
4
(
3
9
%
)
C
A
:
3
2
(
8
0
%
)
S
m
o
k
i
n
g
:
u
n
k
n
o
w
n
V
r
a
u
x
&
B
e
r
t
o
n
c
e
l
l
o
[
3
0
]
4
6
,
5
0
I
I
I
4
(
8
%
)
M
e
d
i
a
n
:
7
5
(
3
5
–
9
2
)
D
M
:
2
8
(
6
1
%
)
P
A
-
C
A
:
2
8
(
5
6
%
)
M
e
d
i
a
n
:
1
5
(
2
–
5
3
)
I
V
4
6
(
9
2
%
)
H
T
:
3
3
(
7
2
%
)
C
A
:
2
2
(
4
4
%
)
S
m
o
k
i
n
g
:
u
n
k
n
o
w
n
L
e
s
i
o
n
(
m
o
s
t
l
y
)
i
n
f
e
m
o
r
a
l
o
r
f
e
m
o
r
o
p
o
p
l
i
t
e
a
l
a
r
t
e
r
y
H
y
n
e
s
[
1
3
]
7
4
,
7
4
I
I
I
2
4
(
3
2
%
)
M
e
a
n
:
7
1
D
M
:
1
7
(
2
3
%
)
F
A
:
7
4
M
e
a
n
:
1
5
I
V
5
0
(
6
8
%
)
H
T
:
u
n
k
n
o
w
n
S
D
:
0
.
6
S
m
o
k
i
n
g
:
4
2
(
5
7
%
)
M
y
e
r
s
[
2
2
]
7
8
,
8
2
I
I
1
0
(
1
2
%
)
M
e
a
n
:
5
9
(
4
2
–
8
8
)
D
M
:
4
9
(
6
3
%
)
F
A
:
8
2
M
e
a
n
:
1
0
I
I
I
5
1
(
6
2
%
)
H
T
:
5
9
(
7
6
%
)
S
D
:
0
.
8
I
V
2
1
(
2
6
%
)
S
m
o
k
i
n
g
:
7
4
(
9
5
%
)
T
r
e
i
m
a
n
[
2
8
]
2
9
,
2
9
I
I
I
1
6
(
5
5
%
)
M
e
a
n
:
7
1
(
4
8
–
8
6
)
D
M
:
1
6
(
5
5
%
)
F
A
:
8
(
2
8
%
)
M
e
a
n
:
3
8
(
2
8
–
5
4
)
I
V
1
3
(
4
5
%
)
H
T
:
2
2
(
7
6
%
)
F
A
-
P
A
:
2
0
(
6
9
%
)
S
m
o
k
i
n
g
:
1
7
(
5
9
%
)
C
A
:
1
(
3
%
)
M
i
x
e
d
l
e
s
i
o
n
s
(
a
l
l
i
n
f
r
a
i
n
g
u
i
n
a
l
)
L
a
z
a
r
i
s
&
T
s
i
a
m
i
s
[
1
7
]
9
9
,
1
1
2
I
I
I
3
2
(
2
9
%
)
M
e
d
i
a
n
:
7
9
(
4
2
–
9
2
)
D
M
:
4
0
(
3
6
%
)
F
A
-
P
A
:
6
2
(
5
5
%
)
M
e
a
n
:
2
0
(
3
–
2
)
I
V
8
0
(
7
1
%
)
H
T
:
5
4
(
4
8
%
)
P
A
-
C
A
:
3
3
(
2
9
%
)
S
m
o
k
i
n
g
:
6
8
(
6
1
%
)
F
A
-
C
A
:
1
7
(
1
5
%
)
L
a
z
a
r
i
s
&
S
a
l
a
s
[
1
8
]
4
6
,
5
1
I
I
I
1
4
(
2
7
%
)
M
e
d
i
a
n
:
8
0
(
4
3
–
9
5
)
D
M
:
1
8
(
3
9
%
)
F
A
-
P
A
:
2
7
(
5
3
%
)
1
2
I
V
3
7
(
7
3
%
)
H
T
:
2
5
(
5
4
%
)
C
A
:
2
4
(
4
7
%
)
S
m
o
k
i
n
g
:
2
2
(
4
8
%
)
S
p
i
n
o
s
a
[
2
6
]
4
0
,
4
4
I
I
I
4
(
9
%
)
M
e
d
i
a
n
:
6
9
(
2
9
–
9
0
)
D
M
:
2
4
(
6
0
%
)
F
A
-
P
A
:
7
(
1
6
%
)
M
e
d
i
a
n
:
8
(
1
–
2
4
)
I
V
4
0
(
9
1
%
)
H
T
:
u
n
k
n
o
w
n
C
A
:
1
5
(
3
4
%
)
S
m
o
k
i
n
g
:
u
n
k
n
o
w
n
F
A
-
C
A
:
2
2
(
5
0
%
)
N
o
t
e
:
D
M
,
d
i
a
b
e
t
e
s
m
e
l
l
i
t
u
s
;
H
T
,
h
y
p
e
r
t
e
n
s
i
o
n
;
F
A
,
f
e
m
o
r
a
l
a
r
t
e
r
y
;
P
A
,
p
o
p
l
i
t
e
a
l
a
r
t
e
r
y
;
C
A
,
c
r
u
r
a
l
a
r
t
e
r
i
e
s
;
F
U
,
f
o
l
l
o
w
-
u
p
R. Met et al.: Subintimal Angioplasty for Peripheral Arterial Occlusive Disease: A Systematic Review 691
123T
a
b
l
e
3
C
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
i
n
c
l
u
d
e
d
s
t
u
d
i
e
s
r
e
p
o
r
t
i
n
g
a
b
o
u
t
p
a
t
i
e
n
t
s
w
i
t
h
c
r
i
t
i
c
a
l
l
i
m
b
i
s
c
h
e
m
i
a
o
r
i
n
t
e
r
m
i
t
t
e
n
t
c
l
a
u
d
i
c
a
t
i
o
n
(
m
i
x
e
d
)
,
s
u
b
d
i
v
i
d
e
d
a
c
c
o
r
d
i
n
g
t
o
l
o
c
a
t
i
o
n
o
f
l
e
s
i
o
n
(
f
e
m
o
r
a
l
o
r
f
e
m
o
r
o
p
o
p
l
i
t
e
a
l
a
r
t
e
r
y
o
r
m
i
x
e
d
l
e
s
i
o
n
s
,
w
h
i
c
h
a
r
e
a
l
l
i
n
f
r
a
i
n
g
u
i
n
a
l
)
S
t
u
d
y
N
o
.
o
f
p
a
t
i
e
n
t
s
,
l
i
m
b
s
F
o
n
t
a
i
n
e
g
r
a
d
e
P
a
t
i
e
n
t
a
g
e
,
y
r
(
r
a
n
g
e
)
P
a
t
i
e
n
t
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
L
o
c
a
t
i
o
n
o
f
l
e
s
i
o
n
s
F
o
l
l
o
w
-
u
p
,
m
o
(
r
a
n
g
e
)
L
e
s
i
o
n
(
m
o
s
t
l
y
)
i
n
f
e
m
o
r
a
l
o
r
f
e
m
o
r
o
-
p
o
p
l
i
t
e
a
l
a
r
t
e
r
y
K
i
d
d
[
1
5
]
4
3
,
4
3
I
I
3
0
(
7
1
%
)
M
e
a
n
:
7
6
(
5
0
–
9
5
)
D
M
:
5
(
1
2
%
)
F
A
-
P
A
:
4
3
A
f
t
e
r
1
y
r
,
1
8
/
4
2
a
t
r
i
s
k
I
I
I
1
0
(
2
4
%
)
H
T
:
2
0
(
4
6
%
)
I
V
2
(
5
%
)
S
m
o
k
i
n
g
:
2
3
(
5
4
%
)
L
a
x
d
a
l
[
1
6
]
1
0
9
,
1
2
4
I
I
8
1
(
6
5
%
)
M
e
a
n
:
7
2
(
3
5
–
9
2
)
D
M
:
1
9
/
1
0
7
(
1
8
%
)
F
A
-
P
A
:
1
2
4
M
e
a
n
:
7
I
I
I
/
I
V
4
3
(
3
5
%
)
H
T
:
4
7
/
1
0
8
(
4
3
%
)
M
e
d
i
a
n
:
3
S
m
o
k
i
n
g
:
5
5
/
1
0
0
(
5
5
%
)
M
c
C
a
r
t
h
y
[
2
1
]
6
6
,
6
9
I
I
2
6
(
3
8
%
)
M
e
d
i
a
n
:
7
4
(
4
7
–
9
2
)
D
M
:
2
0
(
2
9
%
)
F
A
-
P
A
:
6
9
M
e
d
i
a
n
:
8
(
1
–
2
9
)
I
I
I
/
I
V
4
3
(
6
2
%
)
H
T
:
1
8
(
2
6
%
)
S
m
o
k
i
n
g
:
1
8
(
2
6
%
)
R
e
e
k
e
r
s
[
2
]
4
0
,
4
0
I
I
1
1
(
2
8
%
)
M
e
a
n
:
6
9
(
4
2
–
8
7
)
D
M
:
5
(
1
3
%
)
F
A
-
P
A
:
4
0
A
f
t
e
r
1
y
r
I
I
I
2
4
(
6
0
%
)
H
T
:
1
6
(
4
0
%
)
1
7
/
3
4
a
t
r
i
s
k
I
V
5
(
1
3
%
)
S
m
o
k
i
n
g
:
2
7
(
6
8
%
)
S
h
a
w
[
2
4
]
4
6
,
5
0
I
I
2
3
(
4
6
%
)
M
e
d
i
a
n
:
7
2
(
4
5
–
9
3
)
D
M
:
1
4
(
3
0
%
)
F
A
-
P
A
:
4
8
(
9
6
%
)
M
e
d
i
a
n
:
8
(
6
–
1
1
)
I
I
I
/
I
V
2
7
(
5
4
%
)
H
T
:
2
6
(
5
7
%
)
C
A
2
(
4
%
)
S
m
o
k
i
n
g
:
3
4
(
7
4
%
)
S
m
i
t
h
[
2
5
]
4
3
,
4
8
I
I
3
1
(
6
5
%
)
M
e
d
i
a
n
:
7
3
(
4
9
–
9
2
)
D
M
:
1
0
(
2
1
%
)
F
A
4
8
M
e
d
i
a
n
:
2
0
I
I
I
/
I
V
1
7
(
3
5
%
)
H
T
:
2
2
(
4
6
%
)
S
m
o
k
i
n
g
:
3
0
(
6
3
%
)
Y
i
l
m
a
z
[
3
1
]
6
1
,
6
7
I
I
4
1
(
6
7
%
)
M
e
d
i
a
n
:
6
1
D
M
:
1
8
(
3
0
%
)
F
A
6
7
M
e
a
n
:
1
2
.
5
I
I
I
1
8
(
3
0
%
)
(
3
7
–
7
5
)
H
T
:
3
0
(
4
9
%
)
S
D
:
9
I
V
2
(
3
%
)
M
e
a
n
:
6
1
S
m
o
k
i
n
g
:
4
2
(
6
9
%
)
(
1
–
3
0
)
M
i
x
e
d
l
e
s
i
o
n
s
(
a
l
l
i
n
f
r
a
i
n
g
u
i
n
a
l
)
C
h
o
[
1
0
]
3
6
,
4
0
I
I
1
8
(
4
5
%
)
M
e
a
n
:
7
1
D
M
:
2
3
(
6
4
%
)
I
A
:
2
(
5
%
)
M
e
d
i
a
n
:
8
I
I
I
2
(
5
%
)
(
5
7
–
8
3
)
H
T
:
3
0
(
8
3
%
)
F
A
-
P
A
:
1
5
(
3
8
%
)
M
e
a
n
:
1
0
I
V
2
0
(
5
0
%
)
S
m
o
k
i
n
g
:
2
0
(
5
6
%
)
C
A
:
1
5
(
3
8
%
)
(
1
–
2
3
)
F
A
-
C
A
8
(
2
0
%
)
D
e
s
g
r
a
n
g
e
s
[
1
1
]
9
6
,
1
0
0
I
I
4
6
(
4
8
%
)
M
e
a
n
:
7
2
D
M
:
6
3
(
6
6
%
)
F
A
-
P
A
:
8
2
(
8
2
%
)
M
e
a
n
:
1
5
I
I
I
/
I
V
5
0
(
5
2
%
)
(
4
4
–
9
0
)
H
T
:
6
9
(
7
2
%
)
C
A
:
1
8
(
1
8
%
)
1
4
p
t
s
l
o
s
t
t
o
F
U
S
m
o
k
i
n
g
:
6
2
(
6
4
%
)
L
i
p
s
i
t
z
[
1
9
]
3
9
,
3
9
I
I
9
(
2
3
%
)
M
e
d
i
a
n
:
7
4
D
M
:
2
2
(
5
6
%
)
I
A
:
2
(
5
%
)
A
f
t
e
r
1
y
r
,
4
6
%
I
I
I
5
(
1
3
%
)
(
4
6
–
8
9
)
H
T
:
2
0
(
5
1
%
)
F
A
-
P
A
:
3
1
(
7
9
%
)
L
o
s
t
t
o
F
U
I
V
2
5
(
6
4
%
)
S
m
o
k
i
n
g
:
1
4
(
3
6
%
)
C
A
:
6
(
1
5
%
)
T
i
s
i
[
2
7
]
1
4
8
,
1
5
8
I
I
2
9
(
1
8
%
)
M
e
d
i
a
n
:
7
8
D
M
:
4
3
(
2
9
%
)
F
A
-
P
A
:
1
2
2
(
7
7
%
)
A
f
t
e
r
1
y
r
,
2
6
/
1
5
2
a
t
r
i
s
k
I
I
I
/
I
V
1
2
9
(
8
2
%
)
(
7
0
–
8
2
)
H
T
:
7
9
(
5
3
%
)
C
A
:
3
6
(
2
3
%
)
S
m
o
k
i
n
g
:
1
0
6
(
7
2
%
)
N
o
t
e
:
D
M
,
d
i
a
b
e
t
e
s
m
e
l
l
i
t
u
s
;
H
T
,
h
y
p
e
r
t
e
n
s
i
o
n
;
I
A
,
i
l
i
a
c
a
r
t
e
r
y
;
F
A
,
f
e
m
o
r
a
l
a
r
t
e
r
y
;
P
A
,
p
o
p
l
i
t
e
a
l
a
r
t
e
r
y
;
C
A
,
c
r
u
r
a
l
a
r
t
e
r
i
e
s
;
F
U
,
f
o
l
l
o
w
-
u
p
692 R. Met et al.: Subintimal Angioplasty for Peripheral Arterial Occlusive Disease: A Systematic Review
123stenosis in the treated segment; and (3) patency of the
segment without intervention. Deﬁnitions 1 and 2 are taken
together because of the clinical irrelevance of such a dif-
ference. Primary and primary assisted patency were about
50% after 1 year (Tables 5–7).
Limb Salvage
The most common deﬁnition of limb salvage was salvation
of the leg not further speciﬁed. Two studies [18, 26] made
the deﬁnition more explicit, to state that limb salvage was
maintained even when a minor amputation was needed.
Most limb salvage rates are about 80% to 90%, one study
[26] reporting about patients with CLI and mixed lesions
report a limb salvage rate of 66% after 1 year (Tables 5–7).
Survival
Survival was given for different time periods and different
patient selections. Studies reporting only on patients with
CLI showed lower survival rates compared with studies
Critical limb ischemia 
0% 20% 40% 60% 80% 100%
Percentage technical success
Ingle [14]
Nydahl [23]
Vraux, Hammer [29]
Vraux, Bertoncello [30]
Hynes [13]
Myers [22]
Treiman [28]
Lazaris, Tsiamis [17]
Lazaris, Salas [18]
Spinosa [26]
Lesion in crural 
vessels
Lesion in 
femoral or 
femoropopliteal 
artery
Mixed lesions
(all infrainguinal)
Fig. 2 Technical success accompanied by 95% conﬁdence interval of
all studies reporting patients with critical limb ischemia, subdivided
according to location of lesion (crural vessels, femoral or femoro-
popliteal vessels, and mixed lesions, which are all infrainguinal)
Critical limb ischemia and claudication
Percentage technical success
Kidd [15]
Laxdal [16]
McCarthy [21]
Reekers [2]
Shaw [24]
Smith [25]
Yilmaz [31]
Cho [10]
Desgranges [11]
Lipsitz [19]
Tisi [27]
Lesion in 
femoral or 
femoropopliteal 
artery
Mixed lesions
(all infrainguinal)
0% 20% 40% 60% 80% 100%
Fig. 3 Meta-analysis of technical success accompanied by 95%
conﬁdence interval of all studies reporting patients with critical limb
ischemia and claudication (mixed), subdivided according to location
of lesion (femoral or femoropopliteal vessels and mixed lesions,
which are all infrainguinal)
Table 4 Characteristics of included studies reporting about patients with intermittent claudication, subdivided according to location of lesion
(femoral or femoropopliteal artery or mixed lesions, which are all infrainguinal)
Study No. of
patients, limbs
Fontaine grade Patients age,
yr (range)
Patient
characteristics
Location
of lesions
Follow-up,
mo (range)
Lesion (mostly) in femoral or femoral-popliteal artery
London [20] 176, 200 II 178 (89%) Median: 68 (22–92) DM: 33 (19%) FA-PA: 200 (3–60)
III/IV 22 (11%) HT: 62 (35%)
Smoking: 61 (35%)
Mixed lesions (all infrainguinal)
Florenes [12] 104, 116 II 116 (100%) Mean: 67 (31–91) DM: 9 (9%) Inf-ing: 116 Median: 41 (0–79)
HT: 31 (30%)
Smoking: 57 (55%)
Note: DM, diabetes mellitus; HT, hypertension; FA, femoral artery; PA, popliteal artery; FU, follow-up; Inf-ing, infrainguinal
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123reporting patients with different stages of disease. Patients
with CLI and a crural lesion demonstrate a survival after
1 year of from 65%–78%, in contrast to a survival of
between 86% and 100% after 1 year for patients with
mixed disease and a femoral lesion.
Complications
Most frequently reported complications include hematoma
of the groin, perforation of the artery, and distal embolism.
Also, pseudoaneurysms of the femoral artery, retroperito-
neal hematomas, and myocardial infarctions were reported.
Complication rates for all studies were mostly between 8%
and 17%. One study [22], reporting about patients with CLI
and a femoral lesion, reports 2% complications; another
study [2], reporting about patients with mixed disease and
femoral lesions, reports a complication rate of 20%.
Discussion
This systematic review shows that SA can be a useful
option in the treatment of patients with severe critical leg
ischemia. After 1 year, limb salvage rates are between 80%
and 90%, irrespective of whether the occlusion is in the
femoral or femoropopliteal artery or in the crural arteries.
Although there were no comparative studies, SA seems
to have lower patency rates than surgery. The primary
patency of lower limb surgical bypass is high, 83% for an
above-knee femoropopliteal bypass with a saphenous vein
graft, 78% for a PTFE graft [32] and 82% even for a
popliteal-to-distal vein bypass after 1 year [33]. The pri-
mary patency rates after 1 year for SA were about 50%.
The lower patency rates must be balanced against the
advantage that SA is a minimally invasive technique that
requires only local anesthesia, which are great advantages
with respect to surgical revascularization procedures.
Individual patient characteristics, like age and pattern of
disease, will determine the choice between a percutaneous
and a surgical approach.
The beneﬁt of SA for patients with intermittent claudi-
cation is more indistinct. Two studies [12, 20], including
only claudicants, reported a clinical success of 58%, a
primary patency of 56% after 1 year, and a primary
assisted patency of 56% after 3 years. There are several
treatment options for patients with intermittent
Table 5 Outcomes of studies reporting about patients with critical limb ischemia, subdivided according to location of lesion (crural, femoral or
femoropopliteal vessels or mixed, which are all infrainguinal)
Study Statistical
method
Clinical
success (mo)
Complications Primary
patency (mo)
Primary assisted
patency (mo)
Limb
salvage (mo)
Survival
(mo)
Lesion (mostly) in crural vessels
Ingle [14] KMA – 9/70 (13%) – – 94% (12) –
Nydahl [23] KMA 56% (12) 3/28 (11%) 53% (12)
a – 85% (12) –
Vraux & Hammer [29] KMA 68% (12) 5/40 (13%) 56% (12)
b – 81% (12) 78% (12)
Vraux & Bertoncello [30] KMA 63% (12) 7/50 (14%) 46% (12)
b – 87% (12) 65% (12)
Lesion (mostly) in femoral or femoropopliteal artery
Hynes [13] LTA – 6/74 (8%) – – – –
Myers [22] KMA – 2/82 (2%) 74% (3)
a 87% (3) – –
Treiman [28] KMA – 4/29 (14%) 64% (24)
b – 80% (24) 50% (24)
Mixed lesions (all infrainguinal)
Lazaris & Tsiamis [17] KMA 69% (24) 14/112 (13%) – – 88% (12) –
Lazaris & Salas [18] KMA – – 50% (12)
b – 92% (12) 87% (12)
Spinosa [26] KMA – 4/40 (10%) – – 66% (12) 71% (12)
Note: KMA, Kaplan-Meier analysis; LTA, life-table analysis
a Deﬁnition of patency is absence of occlusion and absence of[50% or[30% stenosis in treated segment
b Deﬁnition of patency is patency of segment without intervention
Claudication
Percentage technical success
London [20]
Florenes [12]
Lesion in femoral or 
femoropopliteal 
artery
Mixed lesions
(all infrainguinal)
0% 20% 40% 60% 80% 100%
Fig. 4 Percentage technical success accompanied by 95% conﬁdence
interval of two studies reporting patients with intermittent claudica-
tion. London et al. [20] report about patients with lesions in the
femoral or femoropopliteal vessels; Florenes et al. [12], about patients
with mixed lesions (all infrainguinal)
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123claudication, ranging from conservative to invasive. SA
could be useful in claudicants, but since patency rates are
low, this option should be offered with reserve.
The technical success rates of SA were about 80%, with
higher success rates in the femoral or femoropopliteal
arteries compared with the crural arteries. Although most
studies do not report the experience of the interventional
radiologist, which is an important factor determining out-
come of SA, these good technical success rates could
indicate that the procedure is not only reserved for experts.
Second, the included studies are originating from many
different centers, indicating that many interventionalists
are currently practicing SA, indicating that this technique is
probably not so difﬁcult to learn.
Approximately 15% of the procedures is complicated by
a puncture-site hematoma, vessel perforation, or distal
embolus. This is comparable to the incidence of compli-
cations after PTA (11%) [34]. However, the reported
complication rates ranged between 2% and 20%. It is likely
that various deﬁnitions and different registration systems
for complications were used, which makes these numbers
hard to interpret. It can be argued that complications are
related to the site of the lesion. The risk of a groin hema-
toma does not depend on the site of the lesion, however,
crural vessels are more fragile and might therefore be at
greater risk of perforation. We observed that studies
reporting solely about femoral or femoropopliteal lesions
reported fewer cases of perforation. It should be noted that
major complications, like myocardial infarction, renal
failure, and in-hospital mortality, are probably underre-
ported. In general, such complications should be registered
as well, to fully appreciate the effect of interventions in this
fragile group of patients.
This systematic overview of best evidence has several
limitations. First, the only available publications for this
systematic review were case series (observational studies).
Table 6 Outcomes of studies reporting about patients with critical limb ischemia or intermittent claudication (mixed), subdivided according to
location of lesion (femoral or femoropopliteal artery or mixed lesions, which are all infrainguinal)
Study Statistical
method
Clinical success
(mo)
Complications Primary
patency (mo)
Primary assisted
patency (mo)
Limb
salvage (mo)
Survival
(mo)
Lesion (mostly) in femoral or femoro-popliteal artery
Kidd [15] LTA – – 52% (12)
a – 100% (12) 98% (12)
Laxdal [16] KMA – 9/124 (7%) – 37% (12) 90% (7) –
McCarthy [21] KMA 60% (8) 11/69 (16%) 51% (6)
a – 88% (8) 86% (6)
Reekers [2] LTA 50% (12) 8/40 (20%) 59% (12)
a –– –
Shaw [24] KMA 59% (6) 5/50 (10%) 57% (6)
a – – 89% (6)
Smith [25] KMA – 7/47 (15%) 53% (12)
a –– –
Yilmaz [31] KMA – 10/67 (15%) 22% (12)
a 57% (12) – 100% (12)
Mixed lesions (all infrainguinal)
Cho [10] KMA – 4/40 (10%) 44% (12)
b –– –
Desgranges [11] LTA – 17/100 (17%) 61% (24)
a 69% (24) 78% (24) 85% (24)
Lipsitz [19] LTA 68% (12) 3/39 (8%) 64% (12)
b – 92% (12) –
Tisi [27] LTA – 26/158 (16%) 45% (1)
a –– –
Note: KMA, Kaplan-Meier analysis; LTA, life-table analysis
a Deﬁnition of patency is patency of segment without intervention
b Deﬁnition of patency is absence of occlusion and absence of[50% or[30% stenosis in treated segment
Table 7 Outcomes of studies reporting about patients with intermittent claudication, subdivided according to location of lesion (femoral or
femoropopliteal artery or mixed lesions, which are all infrainguinal)
Study Statistical
method
Clinical
success
(mo)
Complications Primary
patency
(mo)
Primary
assisted
patency (mo)
Limb
salvage
(mo)
Survival
(mo)
Lesion (mostly) in femoral or femoro-popliteal artery
London [20] KMA 58% (12) 15/200 (8%) 56% (12)
a –– –
Mixed lesions (all infrainguinal)
Florenes [12] KMA – 20/116 (17%) – 56% (36) – –
Note: KMA, Kaplan-Meier analysis
a Deﬁnition of patency is absence of occlusion and absence of[50% or[30% stenosis in treated segment
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123An additional limitation is selection bias, which causes
overestimation of treatment effects. Many studies did not
provide data about the entire cohort of patients, including
those who underwent surgery as the initial procedure or
conservativetreatmentinthecaseofclaudication.Moreover,
we must assume publication bias to be likely, another cause
ofoverestimationoftheresults.Todeterminetheexactvalue
ofSA,arandomizedcontrolledtrialinwhichSAiscompared
to surgery would be ideal. From earlier randomized trials in
patientswithcriticallimbischemia(BASILtrial[35]),onlya
small number seems to be eligible for randomization due to
local anatomy. However, experience with SA is still evolv-
ing, and at our hospital bypass surgery for critical limb
ischemia has been reduced by more than 50% over the past
decade,indicatingthatasigniﬁcantnumberofpatientscanbe
treated by SA. A major obstacle for randomized trials is the
preference of patients as well as of treating physicians for
minimally invasive techniques as ﬁrst-line treatment,
knowing that surgery is still in reserve [36].
We noticed a wide variation in reporting of patient
characteristics and in deﬁnitions of outcome and compli-
cations of subintimal angioplasty. First, a whole scale of
outcome measurements and deﬁnitions of outcomes was
used. We have tried to sort out all these different outcomes.
Second, different statistical methods were used to deter-
mine outcome. Most authors did Kaplan-Meier analysis,
whereas others used life-table analysis. Some authors
reported patency and limb salvage rates for the total group
of treated patients; others, only for the technically suc-
cessful cases. Also, data on follow-up were reported
insufﬁciently; the number of patients lost-to-follow-up and
the reasons for that remained unclear most of the time.
These shortcomings in methodology and reporting make it
difﬁcult to compare results, and made us decide not to
perform any meta-analysis. Therefore, we like to stress the
importance of using standards for reporting results of
treatment for peripheral arterial disease and, especially, for
lower-extremity arterial endovascular procedures, to facil-
itate future meta-analyses [37, 38].
In conclusion, this systematic review shows that, espe-
cially in the treatment of critical limb ischemia, SA can play
an important role. Despite the moderate long-term patency
rates of the revascularized segments, SA may serve as a
‘‘temporary bypass’’ to provide wound healing and limb
salvage. Further studies of higher methodological quality
should include and analyze entire cohorts of patients
admitted for CLI, instead of selected series, to better
appreciate the value of SA in relation to bypass surgery.
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Creative Commons Attribution Noncommercial License which per-
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medium, provided the original author(s) and source are credited.
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